Özlem Akbal Dagıstan (Ozlem Akbal-Dagistan, Özlem Akbal-Dağıstan, Özlem Akbal Dağıstan)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Venous Thromboembolism

Childhood Cancer

Top Venues

Current pharmaceutical biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Evren Algın Yapar, Merve Nur Özdemir, Meltem Ezgi Durgun, Özlem Akbal Dagıstan, Daniela Simona Cavalu, Yıldız Ozsoy, Murat Kartal
Nanodelivery Approaches of Phytoactives for Skin Cancers: Current and Future Perspectives. Current pharmaceutical biotechnology (2024)
Evren Algın Yapar, Merve Nur Özdemir, Daniela Simona Cavalu, Özlem Akbal Dagıstan, Yıldız Ozsoy, Murat Kartal
Phytoactive Molecules and Nanodelivery Approaches for Breast Cancer Treatment: Current and Future Perspectives. Current pharmaceutical biotechnology (2024)
Hakan Nazlı, Burcu Mesut, Özlem Akbal Dagıstan, Yıldız Ozsoy
A Novel Semi-Solid Self-Emulsifying Formulation of Aprepitant for Oral Delivery: An In Vitro Evaluation. Pharmaceutics 15 (5) (2023)
Özlem Akbal Dagıstan, Mustafa Sevim, Leyla Semiha Sen, Nur Sena Basarir, Meltem Culha, Aybige Erturk, Hanan Fael, Engin Kaptan, Serap Sancar, Lutfiye Mulazimoglu Durmusoglu, Tessa Corrine Catherina Jaspers, Ayca Yildiz-Pekoz
Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects. Pharmaceutics 14 (11) (2022)
Mustafa Erelel, Mert Kaskal, Özlem Akbal Dagıstan, Halim Issever, Ahmet Serhan Dagistanli, Hilal Balkanci, Merve Sinem Oguz, Aygun Qarayeva, Meltem Culha, Aybige Erturk, Nur Sena Basarir, Gokben Sahin, Ali Yagiz Uresin, Ahmet Ogul Araman, Alpay Medetalibeyoglu, Tufan Tukek, Mustafa Oral Oncul, Ayca Yildiz-Pekoz
Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial. Pharmaceutics 13 (11) (2021)